Patenting Natural Compounds – Effect of Association for Molecular Pathology v. Myriad Genetics, Inc. Supreme Court Ruling on Gene Patents

1 min

Robert Schwartz and Leslie Kushner examine the potential effect of the Association of Molecular Pathology v. Myriad Genetics, Inc. Supreme Court decision that naturally occurring DNA sequences are not patent eligible, because they are products of nature, on the patentability of other isolated naturally occurring compounds.